XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 27, 2025
Sep. 28, 2024
Sep. 27, 2025
Sep. 28, 2024
Revenues:        
Total revenues $ 11,962,425 $ 13,319,608 $ 30,955,800 $ 35,688,672
Expenses:        
Cost of product revenues 8,397,135 8,316,904 23,098,119 25,543,806
Research and development 2,502,988 2,596,649 6,564,345 6,537,065
Selling, general and administration 1,629,175 5,206,880 11,229,549 19,706,613
Litigation damages (5,100,000) (5,100,000) 24,800,000
Total expenses 7,429,298 16,120,433 35,792,013 76,587,484
Income (loss) from operations 4,533,127 (2,800,825) (4,836,213) (40,898,812)
Other (expense) income        
Interest income 281,194 220,017 1,053,944 619,534
Other (expense) income (77,312) 6,176 236,740 25,000
Loss on impairment of investments, net (447,631) (903,609) (472,610) (1,637,895)
Foreign currency transaction (losses) gains (156,774) 142,899 (25,423) 86,618
Total other (expense) income, net (400,523) (534,517) 792,651 (906,743)
Income (loss) before provision for income taxes 4,132,604 (3,335,342) (4,043,562) (41,805,555)
Tax provision (52,000) (125,000) (156,000) (125,000)
Net income (loss) $ 4,080,604 $ (3,460,342) $ (4,199,562) $ (41,930,555)
Net income (loss) per share        
Basic $ 0.02 $ (0.03) $ (0.03) $ (0.34)
Diluted $ 0.02 $ (0.03) $ (0.03) $ (0.34)
Weighted average number of common shares outstanding        
Basic 166,618,201 124,318,056 166,362,609 121,944,597
Diluted 169,448,696 124,318,056 166,362,609 121,944,597
Net Product Revenues [Member]        
Revenues:        
Total revenues $ 10,693,734 $ 10,922,470 $ 27,422,055 $ 31,001,866
Research and Development Revenues [Member]        
Revenues:        
Total revenues 1,199,937 2,268,072 3,344,511 4,338,366
License and Other Revenues [Member]        
Revenues:        
Total revenues $ 68,754 $ 129,066 $ 189,234 $ 348,440